Your Messages Inbox
Your Article Summary
See Latest ArticlesWyeth Submits Two New Drug Applications for Women's Health Therapies
Corporate News Releases - The Healthcare Sales & Marketing Network, 06/27/06
Wyeth Pharmaceuticals, a division of Wyeth, announced that the Company has submitted two New Drug Applications (NDA) to the U.S. Food and Drug Administration (FDA). The first NDA is for the approval of bazedoxifene, a Selective Estrogen Receptor Modulator (SERM) investigated for the prevention of postmenopausal osteoporosis
Today in Regulatory Issues...keeping you current
Receive free subspecialty "5-minute updates" via email
Watson Files FDA Application for Generic Rozerem
Watson Pharmaceuticals, 12/07/09
Bristol-Myers Squibb And Pfizer Announce Plans To Submit Regulatory Filing For Apixaban In Europe
Bristol Myers-Squibb Company, 12/07/09
Non-safety-related voluntary recall of a limited portion of Daytrana (methylphenidate transdermal system) patches announced
Shire, 12/07/09
Article Search
Sponsor